A short video clip from the Socialism 2026 conference in Chicago blew up online this week. In the clip, author and organizer Da’Shaun L. Harrison calls GLP‑1 weight‑loss drugs “fascistic” and says they “genocide fat people.” The remark — excerpted from a panel titled “Health Fascism, Body Politics, and the Anti‑State State” — has been widely shared and roasted across conservative media. The viral moment is the story, and it deserves to be mocked for its theatrical slogans while we remember the real stakes: medicine and patient choice.
Viral Clip: Rhetoric Over Reason at Socialism 2026
Harrison, identified as the co‑executive director of Scalawag Magazine and the author of work about anti‑fatness and race, said in the clip, “The political deployment of GLP‑1s is fascistic, not because individuals take them, but because the conditions under which they become necessary are shaped by a world fixated on genociding fat people.” That line, snipped from a longer discussion, is now the internet’s latest left‑wing theater piece. Conservative outlets ran with the excerpt; conference hosts and progressive sites then posted the full panel to supply context. Context matters — but so does common sense. Calling popular, FDA‑approved medications “fascist” is not critique, it’s performance art.
What GLP‑1 Drugs Actually Are
GLP‑1 receptor agonists — names like Ozempic, Wegovy, Mounjaro, and Zepbound — started as diabetes medicines and also produce significant weight loss for many patients. Doctors prescribe them to reduce blood sugar and, in higher‑dose formulations, to help manage chronic weight issues. Studies show benefits such as lower risk of heart attacks and strokes in some high‑risk patients, and demand for these drugs has surged. People taking these medicines are not pawns in an ideological game. They are patients trying to be healthier. Labeling the drugs “body fascism” does nothing to improve safety, supply, or insurance coverage.
Why This Viral Moment Matters
The clip is a useful window into a wider problem: the politicization of medicine. One side shouts ideological labels; the other looks at outcomes and access. Yes, short clips can strip nuance, and the full panel offers a broader argument about structural pressures and social stigma. But even with context, the claim that a drug class is “fascistic” because of societal pressures on body image is a fancy way of skipping the hard policy work. If the left truly cared about people harmed by a biased health system, it would press for affordability, clear safety guidance, and better care — not punchy slogans that alienate patients who benefited from the same medicines.
Stop the Slogans, Start the Solutions
We should be talking about supply, affordability, real side effects, and fair access to GLP‑1 treatments — not staging rhetorical show trials at conference panels. Ozempic, Wegovy and the rest have real medical uses. They also raise real policy questions about drug pricing and demand. If the goal is better health, then argue solutions that help people: increase access, fund research, and regulate safely. If the goal is applause, call it what it is. This viral moment from Socialism 2026 is a reminder that ideology sometimes prefers slogans to solutions — and that’s bad for patients, science, and common sense.

